Vycor Medical (VYCO) Liabilities and Shareholders Equity (2010 - 2026)
Vycor Medical (VYCO) posted quarterly Liabilities and Shareholders Equity of $854071.0 for Q1 2026, down 9.22% year-over-year from $940831.0 in Q1 2025, and up 2.85% quarter-over-quarter from $830420.0 in Q4 2025.
Vycor Medical (VYCO) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $854071.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 9.22% year-over-year to $854071.0; the TTM figure through Mar 2026 stood at $3.5 million (down 12.61% YoY), while the FY2025 annual figure was $830420.0, down 16.8% from the prior year.
- Liabilities and Shareholders Equity improved to $854071.0 in Q1 2026 per VYCO's latest filing, from $830420.0 in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $1.1 million in Q3 2024 and bottomed at $830420.0 in Q4 2025.
- Historically, Liabilities and Shareholders Equity has averaged $936733.2 across 5 years, with a median of $940831.0 in 2025.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity rose 16.0% — and 2025, when it slipped 16.8%.
- Vycor Medical's Liabilities and Shareholders Equity stood at $860178.0 in 2022, then gained by 15.36% to $992298.0 in 2023, then grew by 0.59% to $998117.0 in 2024, then fell by 16.8% to $830420.0 in 2025, then gained by 2.85% to $854071.0 in 2026.
- Business Quant data shows VYCO's Liabilities and Shareholders Equity at $854071.0 in Q1 2026, $830420.0 in Q4 2025, and $941195.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 813,174.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 854,071.00 |
| Dec 31, 2025 | 830,420.00 |
| Sep 30, 2025 | 941,195.00 |
| Jun 30, 2025 | 878,946.00 |
| Mar 31, 2025 | 940,831.00 |
| Dec 31, 2024 | 998,117.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 996,972.00 |
| Mar 31, 2024 | 968,792.00 |
| Dec 31, 2023 | 992,298.00 |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 905,438.00 |
| Mar 31, 2023 | 835,156.00 |
| Dec 31, 2022 | 860,178.00 |
| Sep 30, 2022 | 949,816.00 |
| Jun 30, 2022 | 910,182.00 |
| Mar 31, 2022 | 932,979.00 |
| Dec 31, 2021 | 935,364.00 |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.06 Mn |